BD PROJECTS

• Insights

  Everest Medicines has strategically increased its stake in I-Mab, becoming its largest shareholder

  2025年8月3日
• Insights

  Merck & Co. is laying off 6,000 employees, and the reason is…

  2025年8月3日
• Insights

  Trump called out 17 pharmaceutical companies to lower drug prices and subsidize the United States!

  2025年8月3日
• Bio News

  I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares

  2025年8月2日
• Bio News

  I-Mab Strengthens Givastomig Intellectual Property Portfolio through Acquisition of Bridge Health

  2025年8月2日
• Insights

  AbbVie boasts that it will become the largest CNS company in the industry next year!

  2025年8月2日
• Product for Licensing

  An asset similar to Roche’s trontinemab | DrugTimes BD Project

  2025年7月31日
• Product for Licensing

  DrugTimes BD Project DT-084 | A GLP-1/GCG/GIP Triagonist for the Treatment of Obesity, Type 2 Diabetes, and Steatohepatitis

  2025年7月31日
• Product for Licensing

  DrugTimes BD Project DTC-059 | Dual-Action FXl/FXla Inhibitor: A Low-Bleeding，Superior-Efficacy Antibody with Best-in-Class Potential

  2025年7月29日
• Pre-clinical

  A Preclinical Menin-MLL Inhibitor for Acute Myeloid Leukemia (AML) Seeking Partners

  2025年7月29日